E-LIB Suche - Ergebnisse für: Chiu, Chao-Hua

1

Trouble with promoting lung cancer screening in never-smoke..:

Chiu, Chao-Hua ; Yu, Chong-Jen ; Chang, Gee-Chen.
The Lancet Respiratory Medicine. 12 (2024) 4 - p. e15 , 2024

Link: https://doi.org/10.1016/..

2

Durvalumab in combination with chemoradiotherapy for patien..:

Kim, Dong-Wan ; Chul Cho, Byoung ; Pachipala, Krishna...
Lung Cancer. 190 (2024) - p. 107530 , 2024

Link: https://doi.org/10.1016/..

3

Brief Report: Updated Efficacy and Safety Data From an Inte..:

Fan, Yun ; Drilon, Alexander ; Chiu, Chao-Hua...
Clinical Lung Cancer. 25 (2024) 2 - p. e81-e86.e4 , 2024

Link: https://doi.org/10.1016/..

4

Low-dose CT screening among never-smokers with or without a..:

Chang, Gee-Chen ; Chiu, Chao-Hua ; Yu, Chong-Jen...
The Lancet Respiratory Medicine. 12 (2024) 2 - p. 141-152 , 2024

Link: https://doi.org/10.1016/..

5

Challenges of lung cancer control in Asia:

Chiu, Chao-Hua ; Yang, Pan-Chyr
eClinicalMedicine. , 2024

Link: https://doi.org/10.1016/..

6

Updated efficacy and safety of entrectinib in NTRK fusion-p..:

Cho, Byoung Chul ; Chiu, Chao-Hua ; Massarelli, Erminia...
Lung Cancer. 188 (2024) - p. 107442 , 2024

Link: https://doi.org/10.1016/..

7

Entrectinib in ROS1-positive advanced non-small cell lung c..:

Peters, Solange ; Gadgeel, Shirish M. ; Mok, Tony...
Nature Medicine. 30 (2024) 7 - p. 1923-1932 , 2024

Link: https://doi.org/10.1038/..

8

Asian Subgroup Analysis of the Randomized Phase 3 CROWN Stu..:

Zhou, Qing ; Soo, Ross A. ; Chang, Gee-Chen...
JTO Clinical and Research Reports. 4 (2023) 5 - p. 100499 , 2023

Link: https://doi.org/10.1016/..

9

Never Say No to Never-Smokers:

Chiu, Chao-Hua ; Yang, Pan-Chyr
Journal of Thoracic Oncology. 18 (2023) 6 - p. 689-693 , 2023

Link: https://doi.org/10.1016/..

10

Proliferative ability of circulating tumor cells is a progn..:

Che, Ting-Fang ; Chiu, Chao-Hua ; Wu, Yu-Chung...
Lung Cancer. 178 (2023) - p. 198-205 , 2023

Link: https://doi.org/10.1016/..

11

Evaluation of combination treatment with DS-1205c, an AXL k..:

Yang, James Chih-Hsin ; Su, Wu-Chou ; Chiu, Chao-Hua...
Investigational New Drugs. 41 (2023) 2 - p. 306-316 , 2023

Link: https://doi.org/10.1007/..

12

Efficacy and Tolerability of Ramucirumab Plus Erlotinib in ..:

Chiu, Chao-Hua ; Lin, Meng-Chih ; Wei, Yu-Feng...
Targeted Oncology. 18 (2023) 4 - p. 505-515 , 2023

Link: https://doi.org/10.1007/..

13

Early Circulating Tumor DNA Dynamics and Efficacy of Lorlat..:

Soo, Ross A. ; Martini, Jean-François ; van der Wekken, Anthonie J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. 1568-1580 , 2023

Link: https://doi.org/10.1016/..

14

Sunvozertinib, a Selective EGFR Inhibitor for Previously Tr..:

Wang, Mengzhao ; Yang, James Chih-Hsin ; Mitchell, Paul L....
Cancer Discovery. 12 (2022) 7 - p. 1676-1689 , 2022

Link: https://doi.org/10.1158/..

15

Updated Integrated Analysis of the Efficacy and Safety of E..:

Demetri, George D. ; De Braud, Filippo ; Drilon, Alexander...
Clinical Cancer Research. 28 (2022) 7 - p. 1302-1312 , 2022

Link: https://doi.org/10.1158/..